Colgate-Palmolive executives and directors sold shares
Between November 4 and November 5, 2026, the CEO, other executives, and directors of Colgate-Palmolive Co. reported sales of company shares. Most of these transactions occurred after they exercised stock options.
Key points
- On November 4, 2026, John Hazlin, chief growth officer, acquired 23,376 shares through option exercises and sold them on the open market the same day.
- On November 5, 2026, Noel R. Wallace, chairman, president, and CEO, sold 20,000 shares.
- All named individuals hold executive or director positions.
Share sales by executives and directors
On November 4, 2026, John Hazlin, chief growth officer, acquired 23,376 shares through option exercises and sold them on the open market the same day. That same day, Panagiotis Tsourapas, a company officer, acquired and subsequently sold 19,938 shares on the open market.
Value of shares sold, by insider
Additional share transactions
On November 5, 2026, Noel R. Wallace, chairman, president, and CEO, sold 20,000 shares. That same day, Lorrie M. Norrington, a director, acquired 4,170 shares through option exercises, which she immediately sold on the open market.
Changes in insider shareholdings
All named individuals hold executive or director positions. These sales do not change the number of shares outstanding because they involve shares already issued and held by insiders.
Status of share sale plans
These filings did not check the box for a "10b5-1 plan," a preset selling schedule executives set up in advance. However, the absence of this check does not necessarily mean no such plan exists.
Next steps for shareholders
Investors should monitor future insider transaction reports in the Securities and Exchange Commission database. These documents allow tracking of any further changes in management's share positions.
Original sources
- 144 filing, November 4, 2026
- 144 filing, November 4, 2026
- 144 filing, November 5, 2026
- 144 filing, November 5, 2026
- 4 filing, November 6, 2026
- 4 filing, November 6, 2026
- 4 filing, November 6, 2026
- 4 filing, November 9, 2026
Cite this article
The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.
Follow Colgate Palmolive
A notification in your browser or on your phone when we publish about Colgate Palmolive. Free, no email, no account, no app.
Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards
